SCHEMBL6652248

SCHEMBL6652248

CC(=O)c1c(C)nc2ccccc2c1NCc1ccc(Br)cc1Cl

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.49
HTT P42858 2/20 0.47
TP53 P04637 2/20 0.45
HSD17B10 Q99714 1/20 0.45
RXFP1 Q9HBX9 2/20 0.42
NCOR2 Q9Y618 2/20 0.42
PRNP P04156 1/20 0.42
PPARG P37231 1/20 0.42
NR2E3 Q9Y5X4 1/20 0.42
PTGFR P43088 1/20 0.39
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
CD38 P28907 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.37
HDAC3 O15379 1/20 0.37
APP P05067 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6653554 0.88 ALDH1A1 (0.49) ALDH1A1HTTTP53HSD17B10RXFP1
SCHEMBL6650864 0.82 TP53 (0.51) ALDH1A1HTTTP53HSD17B10RXFP1
SCHEMBL7649838 0.82 APP (0.54) ALDH1A1HTTTP53HSD17B10RXFP1
SCHEMBL6657077 0.81 TP53 (0.45) ALDH1A1HTTTP53HSD17B10KMT2A
SCHEMBL9821131 0.78 KMT2A (0.59) ALDH1A1HTTTP53HSD17B10KMT2A
SCHEMBL9821276 0.78 MEN1 (0.54) ALDH1A1HTTTP53HSD17B10RXFP1
Hydrochloric Acid SCHEMBL9821072 0.77 KMT2A (0.57) ALDH1A1HTTTP53HSD17B10KMT2A
SCHEMBL7647477 0.75 TP53 (0.45) ALDH1A1HTTTP53HSD17B10KMT2A
SCHEMBL7653573 0.74 APP (0.52) ALDH1A1HTTTP53HSD17B10RXFP1
SCHEMBL9821213 0.73 HTT (0.52) ALDH1A1HTTTP53HSD17B10KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1218401-B1 4-BENZYLAMINOQUINOLINE CONJUGATES WITH BILE ACID AND THEIR HETEROANALOGUES, METHODS FOR PRODUCING THE SAME, MEDICAMENTS CONTAINING THESE COMPOUNDS AND THEIR USE AVENTIS PHARMA GMBH (DE) 2004-06-16 EP disclosed
EP-1218401-A1 4-BENZYLAMINOQUINOLINE CONJUGATES WITH BILE ACID AND THEIR HETEROANALOGUES, METHODS FOR PRODUCING THE SAME, MEDICAMENTS CONTAINING THESE COMPOUNDS AND THEIR USE Aventis Pharma Deutschland GmbH (DE) 2002-07-03 EP disclosed
US-6339077-B1 FOR PROPHYLAXIS OR OF GALLSTONES AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2002-01-15 US disclosed
WO-2001021642-A1 4-BENZYLAMINOQUINOLINE CONJUGATES WITH BILE ACID AND THEIR HETEROANALOGUES, METHODS FOR PRODUCING THE SAME, MEDICAMENTS CONTAINING THESE COMPOUNDS AND THEIR USE AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2001-03-29 WO disclosed